Literature DB >> 2535611

High-grade non-Hodgkin lymphoma relapsing as low-grade follicular lymphoma: so-called downgraded lymphoma.

D P Kerrigan1, K Foucar, L Dressler.   

Abstract

Evolution of low-grade Non-Hodgkin Lymphoma (NHL) into a more aggressive neoplasm is a common, well-documented event in NHL. The reverse process, in which a less aggressive component becomes evident during the course of treatment for a higher-grade NHL, has only recently been recognized. This lymphoma "downgrading" has been reported at the time of relapse in both radiation- and chemotherapy-treated patients who initially presented with high- or intermediate-grade lymphoma. The etiology of this unusual transformation has not yet been determined. We present the clinical, morphologic, immunologic, and flow-cytometric features of a patient with diffuse immunoblastic lymphoma who achieved a complete response to chemotherapy and then relapsed with follicular small-cleaved-cell lymphoma 3 years later. Morphologic and immunophenotypic findings suggest that both immunoblasts and small cleaved cells were present in the initial biopsy. DNA content analysis of the initial and relapse biopsies suggests that the immunoblastic component was more susceptible than the small cleaved cells to the chemotherapy that the patient received. Successful eradication of the rapidly proliferating immunoblasts with survival of less rapidly proliferating small cleaved cells may account for the unusual histologic transformation seen in this case.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535611     DOI: 10.1002/ajh.2830300108

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Long-term follow-up of CHOP-treated non-Hodgkin lymphoma of high-grade malignancy.

Authors:  R Heinz
Journal:  Blut       Date:  1990-02

2.  Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma--De Novo Occurrence or Transformation.

Authors:  Smeeta Gajendra; Bhawna Jha; Shalini Goel; Tushar Sahni; Pranav Dorwal; Ritesh Sachdev
Journal:  Turk J Haematol       Date:  2015-09-28       Impact factor: 1.831

3.  Comment: In Response to "Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma - De Novo Occurrence or Transformation".

Authors:  Burak Uz; Kadir Acar
Journal:  Turk J Haematol       Date:  2016-04-18       Impact factor: 1.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.